Acadia Healthcare Company, Inc. (ACHC) FinancialsACHCFinancialAcadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc. (ACHC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Operating Segment – U.S.Facilities, accounting for 65.8% of total sales, equivalent to $547.96M. Another important revenue stream is Operating Segment – U.K.Facilities. Understanding this composition is critical for investors evaluating how ACHC navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Acadia Healthcare Company, Inc. maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 10.14%, while the net margin is 1.42%. These profitability ratios, combined with a Return on Equity (ROE) of -44.54%, provide a clear picture of how effectively ACHC converts its operational activities into shareholder value.

In the context of the broader market, ACHC competes directly with industry leaders such as WGS and AVAH. With a market capitalization of $2.87B, it holds a leading position in the sector. When comparing efficiency, ACHC's gross margin of 100.00% stands against WGS's 68.37% and AVAH's 32.17%. Such benchmarking helps identify whether Acadia Healthcare Company, Inc. is trading at a premium or discount relative to its financial performance.

Acadia Healthcare reported a revenue of $866 million for Q2 2026, which was flat year-over-year, and a net income of $10.9 million, indicating a struggle to grow profits despite stable revenue.